3 Results for "

CT26.WT

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "CT26.WT" in MCE Product Catalog:

Cat. No.: HY-122168
CAS No.: 847727-81-5
Purity:  98.55%
Research Areas:  

Inflammation/Immunology Cancer

AAT-008 is a potent, selective, and orally active prostaglandin EP4 receptor antagonist with Kis of 0.97 and 6.1 nM for recombinant human EP4 and recombinant rat EP4, respectively. AAT-008 exerts tumor growth delay in mice bearing CT26WT colon tumors when combined with radiotherapy. AAT-008 can be used for the study of acute and chronic inflammatory pain and cancer .
loading...
    loading...
Cat. No.: HY-P10837
Target:  

LAG-3

Research Areas:  

Inflammation/Immunology Cancer

LAG-3 cyclic peptide inhibitor 12 (Cyclic peptide 12) is an inhibitor of LAG-3 with an IC50 value of 4.45 μM and a Ki value of 2.66 µM .
loading...
    loading...
Cat. No.: HY-174301
CAS No.: 3052223-40-9
Research Areas:  

Cancer

USP7-IN-18 is a naphthalene derivative. USP7-IN-18 is a selective USP7 inhibitor (IC50 : 130.9 nM), with no or very weak inhibition of the other 8 DUBs including USP47. USP7-IN-18 specifically binds to the catalytic domain of USP7, blocking its deubiquitinase activity. USP7-IN-18 causes degradation of the oncogenic proteins MDM2 and DNMT1, and also degrades the novel target PCLAF. USP7-IN-18 activates the p53-p21 pathway. USP7-IN-18 exerts anti-tumor effects in colon cancer animal models and reshapes the tumor immune microenvironment. USP7-IN-18 achieves both direct cytotoxic and immune-synergistic anti-tumor actions.
loading...
    loading...